Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DMAC DiaMedica Therapeuti... | Reiterates: Buy | 12 12 | 4.6 | 160.87% | 7 | Aug 15, 2025 | |
LYRA Lyra Therapeutics | Reiterates: Neutral | 16 16 | 6.67 | 139.88% | 9 | Aug 14, 2025 | |
MLYS Mineralys Therapeuti... | Reiterates: Buy | 42 42 | 13.2 | 218.18% | 10 | Aug 13, 2025 | |
FBLG FibroBiologics | Maintains: Strong Buy | 10 12 | 0.55 | 2081.82% | 5 | Aug 5, 2025 | |
LENZ LENZ Therapeutics | Maintains: Strong Buy | 48 56 | 38.72 | 44.63% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 1.07 | 647.66% | 4 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 10 | 5.4 | 85.19% | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 10.3 | 94.17% | 10 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 8 | 3.35 | 138.81% | 1 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | n/a | n/a | 9 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 72 | 50.08 | 43.77% | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 9 9 | 9.6 | -6.25% | 8 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 5.24 | 90.84% | 13 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 14.97 | 100.4% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 2.23 | 1245.29% | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 32 | 10 | 220% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 0.84 | 1090.48% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 2.07 | -3.38% | 6 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 3 | 8.04 | -62.69% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 12 2 | 3.41 | -41.35% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 15.82 | -87.36% | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 36 36 | 5.53 | 550.99% | 18 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 18 | 1.17 | 1438.46% | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 | 332.39 | -91.58% | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | 39.95 | 0.13% | 6 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 11.17 | 79.05% | 1 | Jul 18, 2022 |